×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 5: The IND in Detail - Additional Topics
Session Chair(s)
Drusilla Scott, PhD, RAC
Vice President, Regulatory Affairs
Sobi, Inc., United States
- Additional Requirements for Biologics and Biotechnology-Derived Products
- Submission of an Original IND
Have an account?